In the rapidly evolving landscape of military technology, the convergence of biology and electromagnetism has paved the way for the development of novel biological-electromagnetic agents (BEAs). This paper presents a comprehensive exploration of the theoretical framework, experimental methodologies, and strategic implications associated with the creation and deployment of BEAs for advanced warfare applications. Drawing inspiration from emerging trends in synthetic biology and quantum computing, we propose a paradigm shift in the utilization of genetically engineered microorganisms as carriers of electromagnetic signals. By encoding genetic sequences with specific instructions for signal generation and modulation, researchers can harness the inherent capabilities of living systems to emit non-traceable electromagnetic waves. The deployment of Experimental Biological Operations (EBO) represents a pivotal aspect of this futuristic endeavor, encompassing the design, development, and field testing of genetically engineered BEAs. Through meticulous planning and operational experimentation, military strategists aim to leverage BEAs to disrupt enemy infrastructure, exert strategic influence on the battlefield, and evade traditional detection and countermeasures. Countermeasures against BEAs pose a formidable challenge, requiring the integration of passive detection systems, active neutralization protocols, and strategic preparedness measures. Passive detection and surveillance systems leverage advanced sensor technologies and machine learning algorithms to monitor environmental signals for signs of anomalous activity, while active neutralization protocols employ chemical disinfection and biological remediation strategies to eliminate hostile agents. Furthermore, strategic preparedness and response planning are essential for effectively addressing the multifaceted threats posed by BEAs. By fostering collaboration among international stakeholders and investing in research and development initiatives, nations can enhance their resilience and preparedness to confront the complex challenges of biological-electromagnetic warfare in the 21st century. In conclusion, the emergence of BEAs heralds a new era in military strategy, where the fusion of biology and electromagnetism offers unprecedented opportunities for strategic advantage. By embracing a forward-thinking approach to research, development, and international cooperation, nations can navigate the complexities of modern warfare and safeguard global security in an era of uncertainty and rapid technological advancement.
Keywords: Biological-electromagnetic agents, Experimental Biological Operations (EBO), Synthetic biology, Quantum computing, Genetic engineering, Passive detection systems, Active neutralization protocols, Strategic preparedness, International cooperation, Military strategy, Countermeasures, Resilience in warfare.
[1] Montagnier, L., Aïssa, J., Del Giudice, E., Lavallee, C., Tedeschi, A., & Vitiello, G. (2011). DNA waves and water. Journal of Physics: Conference Series, 306: 1–10.
[2] França T.C., Guimarães, A.P., Cortopassi, W.A., Oliveira, A.A., & Ramalho, T.C. (2013). Applications of Docking and Molecular Dynamic Studies on the Search for New Drugs Against the Biological Warfare Agents Bacillus anthracis and Yersinia pestis. Curr Comput Aided Drug Des., 9(4): 507–17.
[3] Selgelid, M.J. (2009). Governance of dual–use research: an ethical dilemma. Bull World Health Organ., 87: 720–723.
[4] Hijawi, B., Abdallat, M., Sayaydeh, A., Alqasrawi, S., Haddadin, A., Jaarour, N., Alsheikh, S., & Alsanouri, T. (2013). Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J., 19(S.1): S12–18.
[5] Pedraza, J.M. (2012). The Need to Establish the Organisation for the Prohibition of Biological Weapons (OPBW): A Proposal for the Future. Public Organiz Rev., 12: 57–70.
[6] Bhalla, D.K., & Warheit, D.B. (2004). Biological agents with potential for misuse: a historical perspective and defensive measures. Toxicol Appl Pharmacol., 199: 71–84.
[7] Ambrus, J.L. Sr., Ambrus, C.M., Ambrus, J.L. Jr., Akhter, S., Zaidi, S., Rohilla, R., & Baig, M.S. (2007). Bioterror, agroterror, and new diseases. Discov Med., 7(38): 82–87.
[8] Ilchmann, K., & Revill, J. (2013). Chemical and Biological Weapons in the 'New Wars'. Sci Eng Ethics, Ahead of Print.
[9] Montagnier, L., Aïssa, J., Ferris, S., Montagnier, J.L., & Lavallée, C. (2009). Electromagnetic signals are Produced by aqueous nanostructures derived from bacterial DNA sequences. Interdiscip Sci Comput Life Sci., 1: 81–90.
[10] Yutin, N., & Koonin, E.V. (2013). Pandoraviruses are highly derived phycodnaviruses. Biol. Direct., 8: 25–33.
[11] Bitam, I., Dittmar, K., Parola, P., Whiting, M.F., & Raoult, D. (2010). Fleas and flea-borne diseases. Int J Infect Dis., 14(8): e667–76.
[12] Hu, W.G., & Nagata, L.P. (2008). Antibody gene-based prophylaxis and therapy for biodefence. Hum Vaccin., 4(1): 74–8.
[13] Immai, M., Watanabe, T., Hatta, M., Das, S.C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., Li, C., Kawakami, E., Yamada, S., Kiso, M, Suzuki, Y., Maher, E.A., Neumann, G., & Kawaoka, Y. (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 486: 420–428.
[14] Black, J.L. (2003). Genome projects and gene therapy: gateways to next generation biological weapons. Military Medicine, 168: 864–871.
[15] Ambrus, J.L. Sr., Ambrus, C.M., Ambrus, J.L. Jr., Akhter, S., Zaidi, S., Rohilla, R., & Baig, M.S. (2007). Bioterror, agroterror, and new diseases. Discov Med., 7(38): 82–87.
[16] Bell, S.S., White, A., Sherratt, J.A., & Boots, M. (2009). Invading with biological weapons: the role of shared disease in ecological invasion. Theor Ecol., 2: 53–66.
[17] Cohen, H.W., Sidel, V.W., & Gould, R.M. (2001). Preparedness for Bioterrorism?. N Engl J Med., 345(8): 1423–1424.
[18] Cenciarelli Orlando, Rea Silvia, Carestia Mariachiara, D’Amico Fabrizio, Malizia Andrea, Bellecci Carlo, Gaudio Pasquale, Gucciardino Antonio & Fiorito Roberto. (2013). Biological Weapons and Bio-Terrorism: a Review of History and Biological Agents. Defence S&T Tech Bull., 6(2): 111–129.
[19] D'Agostino, M., & Martin, G. (2009). The bioscience revolution & the biological weapons threat: levers & interventions. Global Health, 5: 3–7.
[20] Del Giudice, E., & Tedeschi, A. (2009). Water and the autocatalysis in living matter. Electromagnetic Biology and Medicine, 28: 46–50.
[21] Douet, J.Y., Zafar, S., Perret-Liaudet, A., Lacroux, C., Lugan, S., Aron, N., Cassard, H., Ponto, C., Corbière, F., Torres, J.M., Zerr, I., & Andreoletti, O. (2014). Detection of infectivity in blood of persons with variant and sporadic creutzfeldt-jakob disease. Emerg Infect Dis., 20(1): 114–7.
[22] DaSilva, E.J. (1999). Biological warfare, bioterrorism, biodefence and the biological and toxin weapons convention. Electronic Journal of Biotechnology, 2(3): 99–129.
[23] Gouvras, G. (2004). Policies in place throughout the world: action by the European Union. International Journal of Infectious Diseases, 8(S2): S21–S30.
[24] Barria, M.A., Balachandran, A., Morita, M., Kitamoto, T., Barron, R., Manson, J., Knight, R., Ironside, J.W., & Head, M.W. (2014). Molecular barriers to zoonotic transmission of prions. Emerg Infect Dis., 20(1): 88–97.
[25] Montagnier, L., Aïssa, J., Lavallee, C., Mbamy, M., Varon, J., & Chenal, H. (2009). Electromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapy. Interdiscip Sci Comput Life Sci., 1: 245–253.
[26] Alibek, K. (2004). Smallpox: a disease and a weapon. Int J Infect Dis., 8(S2): S3–8.
[27] Bhargava, P.M. (2003). Ethical issues in modern biological technologies. Reprod Bio Online, 7(3): 276–85.
[28] Moss, B. (2011). Smallpox vaccines: targets of protective immunity. Immunol Rev., 239(1): 8–26.
[29] National Research Council (2004). Biotechnology research in an age of terrorism. http://www.nap.edu/cata log/10827.html Washington, DC. Nat. Ac. Press.
[30] Raoult, D., & Forterre, P. (2008). Redefining viruses: lessons from Mimivirus. Nat Rev Microb., 6: 315–319.
[31] McLain, D.E., Lewis, B.S., Chapman, J.L., Wannemacher, R.W., Lindsey, C.Y., & Smith, L.A. (2012). Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response,and histopathological findings. Toxicol Sci., 126(1): 72–83.
[32] Korevaar, D.A., & Visser, B.J. (2013). Reviewing the evidence on nodding syndrome, a mysterious tropical disorder. Int J Infect Dis., 17(3): e.149–52.
[33] Kumar, A., Verma, A., Yadav, M., Sabri, I., & Asthana, A. (2011). Biological Warfare, Bioterrorism and Biodefence. J Indian Acad Forensic Med., 33(1): 69–73.
[34] Norwood, A.E. (2001). Psychological effects of biological warfare. Military Medicine, 166(12): 27–8.
[35] O.M.S. (2004). Public health response to biological and chemical weapons: WHO guidance. http://www.who. int/csr/delibepidemics/biochemguide/en/org. Mondiale della Sanità.
[36] Cogo, P.E., Scagli, M., Gatti, S., Rossetti, F., Alaggio, R., Laverda, A.M., Zhou, L., Xiao, L., & Visvesvara, G.S. (2004). Fatal Naegleria fowleri meningoencephalitis, Italy. Emerg Infect Dis., 10(10): 1835–7.
[37] Ispe.Armi.NBC (Ispettorato delle armi dell’esercito - Scuola interforze per la difesa NBC) (2000). Aggressivi biologici. Pubblicazione N.6295.
[38] Philippe, N., Legendre, M., Doutre, G., Couté, Y., Poirot, O., Lescot, M., Arslan, D., Seltzer, V., Bertaux, L., Bruley, C., Garin, J., Claverie, J.M., & Abergel, C. (2013). Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes. Science, 341: 281–286.
[39] Van Aken, J., & Hammond, E. (2003). Genetic engineering and biological weapons. EMBO Rep., 4(S1): S57–S60.
[40] Ilchmann, K., & Revill, J. (2013). Chemical and Biological Weapons in the 'New Wars'. Sci Eng Ethics, Ahead of Print.
[41] Cohen, H.W., Sidel, V.W., & Gould, R.M. (2001). Preparedness for Bioterrorism?. N Engl J Med., 345(8): 1423–1424.
[42] Agarwal, R., Shukla, S.K., Dharmani, S., & Gandhi, A. (2004). Biological Warfare – An Emerging Threat. Journal of the Association of Physicians of India, 52: 733–738.
[43] Barash, J.R., & Arnon, S.S. (2013). A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins. J Infect Dis., Ahead of Print.
[44] Marmo Federico & Urbano Francesco (2007). Il vaiolo, flagello dell'umanità. Rassegna dell'Esercito, 3.
[45] Ambrus, J.L. Sr., Ambrus, C.M., Ambrus, J.L. Jr., Akhter, S., Zaidi, S., Rohilla, R., & Baig, M.S. (2007). Bioterror, agroterror, and new diseases. Discov Med., 7(38): 82–87.
[46] McLain, D.E., Lewis, B.S., Chapman, J.L., Wannemacher, R.W., Lindsey, C.Y., & Smith, L.A. (2012). Protective effect of two recombinant ricin subunit vaccines in the New Zealand white rabbit subjected to a lethal aerosolized ricin challenge: survival, immunological response,and histopathological findings. Toxicol Sci., 126(1): 72–83.
[47] Bhalla, D.K., & Warheit, D.B. (2004). Biological agents with potential for misuse: a historical perspective and defensive measures. Toxicol Appl Pharmacol., 199: 71–84.
[48] DaSilva, E.J. (1999). Biological warfare, bioterrorism, biodefence and the biological and toxin weapons convention. Electronic Journal of Biotechnology, 2(3): 99–129.
[49] Ispe.Armi.NBC (Ispettorato delle armi dell’esercito - Scuola interforze per la difesa NBC) (2000). Aggressivi biologici. Pubblicazione N.6295.
[50] França T.C., Guimarães, A.P., Cortopassi, W.A., Oliveira, A.A., & Ramalho, T.C. (2013). Applications of Docking and Molecular Dynamic Studies on the Search for New Drugs Against the Biological Warfare Agents Bacillus anthracis and Yersinia pestis. Curr Comput Aided Drug Des., 9(4): 507–17.
[51] Hu, W.G., & Nagata, L.P. (2008). Antibody gene-based prophylaxis and therapy for biodefence. Hum Vaccin., 4(1): 74–8.
[52] Selgelid, M.J. (2009). Governance of dual-use research: an ethical dilemma. Bull World Health Organ., 87: 720–723.
[53] Moss, B. (2011). Smallpox vaccines: targets of protective immunity. Immunol Rev., 239(1): 8–26.
[54] Montagnier, L., Aïssa, J., Del Giudice, E., Lavallee, C., Tedeschi, A., & Vitiello, G. (2011). DNA waves and water. Journal of Physics: Conference Series, 306: 1–10.
[55] Hijawi, B., Abdallat, M., Sayaydeh, A., Alqasrawi, S., Haddadin, A., Jaarour, N., Alsheikh, S., & Alsanouri, T. (2013). Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J., 19(S.1): S12–18.
[56] Pedraza, J.M. (2012). The Need to Establish the Organisation for the Prohibition of Biological Weapons (OPBW): A Proposal for the Future. Public Organiz Rev., 12: 57–70.
[57] Norwood, A.E. (2001). Psychological effects of biological warfare. Military Medicine, 166(12): 27–8.
[58] Col.me Stefano Astorino. Biotecnologie, Guerra Biologica E Bioterrorismo: Nuovi Agenti Come Armi Biologiche. Università degli Studi “ROMA TOR VERGATA”, Facoltà di Ingegneria e Facoltà di Medicina e Chirurgia, Master di II livello in “Protezione da eventi CBRNe”, Relatore: Chiar.mo Prof. Roberto Fiorito, Correlatore: Chiar.mo Prof. Francesco Urbano, Anno Accademico 2012/2013.
Source of Funding:
This study did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.
Competing Interests Statement:
The author declares no competing financial, professional, and personal interests.
Consent for Publication:
Author declares that he consented for the publication of this study.
